Health TrialsbyHealthPanel

Establishing Prospective Mediastinal Tumor Database of PUMCH

ConditionsThymic Epithelial TumorTeratomaThymic CystRetrosternal GoitreGerm Cell TumorLymphomaSchwannoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPeking Union Medical College Hospital

About this trial

This study aims to prospectively document the population characteristics, imaging findings, pathological features, prognostic factors, etc., of patients with mediastinal tumors. Clinical information will be structured and processed, and it is recommended to establish a mediastinal tumors database at Peking Union Medical College Hospital. The goal is to provide support for the quality of diagnosis and treatment, clinical protocols, and medical decision-making related to mediastinal tumors.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Clinical or pathological diagnosis of mediastinal tumors;

Written consent is able to obtained.

Disqualifiers

None

Trial population

Patients diagnosed with mediastinal tumors clinically or pathologically.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

2,000 Participants
are grouped into 8 trial groups

8

Trial groups

See each trial group below.

Group A: thymoma
Group B: teratoma
Group C: germ cell tumor
Group D: lymphoma
Group E: mediastinal neuroendocrine tumors (NETs)
Group F: neurinoma
Group G: thymic carcinoma
Group H: others

Trial outcomes

Primary outcomes

1

Overall survival (OS)

Overall survival of patients with mediastinal tumors

Time frame
From date of enrollment until the date of death from any cause, assessed up to 20 years

Secondary outcomes

1

Progression free survival (PFS)

Progression free survival of patients with mediastinal tumors

Time frame
From date of enrollment until the date of first documented progression, assessed up to 20 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Peking Union Medical College Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now